✦ LIBER ✦

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

✍ Scribed by Zhu, Feng-Cai; Liang, Zheng-Lun; Li, Xiu-Ling; Ge, Heng-Ming; Meng, Fan-Yue; Mao, Qun-Ying; Zhang, Yun-Tao; Hu, Yue-Mei; Zhang, Zhen-Yu; Li, Jing-Xin; Gao, Fan; Chen, Qing-Hua; Zhu, Qi-Yan; Chu, Kai; Wu, Xing; Yao, Xin; Guo, Hui-Jie; Chen, Xiao-Qin; Liu, Pei; Dong, Yu-Ying; Li, Feng-Xiang; Shen, Xin-Liang; Wang, Jun-Zhi

Book ID: 120045521
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 166 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(12)61764-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a novel hum

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial

✍ Yan-Ping Li; Zheng-Lun Liang; Qiang Gao; Li-Rong Huang; Qun-Ying Mao; Shu-Qun We 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Efficacy, safety, and immunology of an i

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

✍ Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Li, Xiu-Ling; Mao, Qun-Ying; Tao, Ho 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 263 KB

Safety, immunogenicity, and tolerability

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

✍ Richmond, Peter C; Marshall, Helen S; Nissen, Michael D; Jiang, Qin; Jansen, Kat 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 293 KB

Efficacy and safety of a recombinant hep

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

✍ Feng-Cai Zhu; Jun Zhang; Xue-Feng Zhang; Cheng Zhou; Zhong-Ze Wang; Shou-Jie Hua 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 272 KB

Safety and immunogenicity of SC599, an o

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

✍ Odile Launay; Christine Sadorge; Nathalie Jolly; Béatrice Poirier; Stéphane Béch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 795 KB

Clinical efficacy and safety of a novel

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

✍ Capeding, Maria Rosario; Tran, Ngoc Huu; Hadinegoro, Sri Rezeki S; Ismail, Hussa 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 435 KB